-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
●新型インフルエンザ：国内上場企業の過半数、対策なし
http://mainichi.jp/select/science/archive/news/2008/07/09/20080709ddm002040076000c.html
●半数超が「対応予定なし」 新型インフルで上場４５０社調査
http://www.47news.jp/news/2008/07/post_1454.html
●The long war against flu
http://www.nature.com/nature/journal/v454/n7201/full/454137a.html
▼That the H5N1 strain of bird flu has not yet caused a pandemic is no cause for complacency. Preparations for the inevitable must be redoubled to mitigate the potential devastation.
●The contents of the syringe
http://www.nature.com/nature/journal/v454/n7201/full/454160a.html
▼The influenza vaccine failed this winter. Steven Salzberg suggests that future success relies on sharing data more widely and making the virus strain selection process more transparent.
Steven Salzberg
●Ready for avian flu?
http://www.nature.com/nature/journal/v454/n7201/full/454162a.html
▼Committing to a vaccine stockpile is just the beginning. Tadataka Yamada, Alice Dautry and Mark Walport offer a roadmap for heading off a global avian influenza catastrophe.
Tadataka Yamada, Alice Dautry & Mark Walport
